ROTFL.It is effortless to create a tender specification that can only be won by using a certain product. In fact it is so common that nobody even bats an eyelid. Virtually every trial where Edencrete has been used seems to be an obscure scenario cherry picked to favour the product.
In the real world (private sector) where cost and performance are taken seriously Edencrete has had essentially zero success. In fact I doubt it could win any major tender based on performance and cost benefit analysis.
- Forums
- ASX - By Stock
- EDE
- Ann: EdenCrete - GDOT Sales and Marketing Update
Ann: EdenCrete - GDOT Sales and Marketing Update, page-29
Featured News
Add EDE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.001(100%) |
Mkt cap ! $8.216M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $129 | 64.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
56 | 130683047 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 13252283 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
55 | 130648047 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 11007283 | 12 |
0.003 | 34879714 | 24 |
0.004 | 6587627 | 6 |
0.005 | 978500 | 3 |
0.006 | 245010 | 2 |
Last trade - 11.51am 15/11/2024 (20 minute delay) ? |
Featured News
EDE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online